TENAX (TENX) Form 13G Filing on June 5 Revealed Stake

AI Summary

On June 5, Tenax Therapeutics Inc (TENX) filed a Form 13G, detailing a new stake. The filing indicates significant ownership changes in the company, which typically affect market perception and investment decisions. Such filings are crucial for investors to understand shareholding trends and regulatory compliance. The specifics of the stakes or percentages were not provided, but the filing belongs to regulatory requirements in public markets.